Detalles de la búsqueda
1.
Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies.
J Biol Chem
; 291(26): 13846-54, 2016 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27129274
2.
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions.
Biochem Pharmacol
; 158: 413-424, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342023
3.
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry.
Biochem Pharmacol
; 158: 402-412, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342024
4.
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops.
MAbs
; 8(6): 1126-35, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27211075
5.
Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.
Protein Eng Des Sel
; 29(4): 123-33, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26945588
6.
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.
MAbs
; 7(4): 693-706, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018625
Resultados
1 -
6
de 6
1
Próxima >
>>